Shares in this article
DSSELDORF (dpa-AFX) – After dazzling annual figures, the medical device manufacturer Gerresheimer wants to provide information on the course of business in the first quarter of 2021 this Thursday. The company with around 10,000 employees has benefited in part from the consequences of the corona pandemic – the need for vaccine bottles has gone through the roof, with Schott from Mainz and Stevanato from Italy, Gerresheimer is one of the world’s largest producers of vaccine bottles. By the end of 2022, the company plans to deliver around a billion such containers for corona vaccinations to various pharmaceutical companies.
Gerresheimer manufactures the glass bottles for corona vaccines for the European market in Chalon (France) and in Boleslawiec (Poland). The containers are also manufactured in Bnde in Ostwestfalen, but these structurally identical products are used, among other things, as packaging for cancer drugs and special biotech preparations.
The former beer bottle manufacturer with a long-closed glass hut in Dsseldorf has specialized in medical products, including glass syringes. The glass and plastic packaging is used for cough syrups, eye drops, nasal sprays, asthma inhalers and as insulin pens – and also for vaccines. In 2020, consolidated sales rose slightly to 1.4 billion euros, while net profit climbed 7.2 percent to 89.9 million euros. The fourth quarter of 2020 in particular was strong./wdw/DP/fba